Clinical Trial Update: Intrathecal Hydromorphone for Pain Control After Cesarean Section [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intrathecal hydromorphone for pain control after cesarean section has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesarean Section
• Pain

Drugs mentioned

• Hydromorphone (hydromorphone)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Pain, Cesarean Section | Phase 2 | Status: COMPLETED | Results posted: 2019-08-20